Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 重組抗體
  4. SEMA4D Recombinant Monoclonal Antibody

SEMA4D Recombinant Monoclonal Antibody

  • 中文名稱：
    SEMA4D重組抗體
  • 貨號：
    CSB-RA835707A1HU
  • 規(guī)格：
    ￥1320
  • 圖片：
    • Untransfected HEK293T cells surface (green line) and transfected Human SEMA4D HEK293T stable cells surface (red line) were stained with anti-SEMA4D antibody (2μg/1*106 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.
    • The Binding Activity of Mouse Sema4d with Anti-SEMA4D recombinant antibody.
      Activity: Measured by its binding ability in a functional ELISA. Immobilized Mouse Sema4d (CSB-MP020990MO) at 2 μg/mL can bind Anti-SEMA4D recombinant antibody, the EC50 is 98.14-174.8 ng/mL.
    • The Binding Activity of Human SEMA4D with Anti-SEMA4D recombinant antibody.
      Activity: Measured by its binding ability in a functional ELISA. Immobilized Human SEMA4D (CSB-MP835707HU) at 2 μg/mL can bind Anti-SEMA4D recombinant antibody, the EC50 is 1.082-4.805 ng/mL.
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：

    The SEMA4D recombinant monoclonal antibody is a highly specific antibody against the SEMA4D protein. This SEMA4D antibody was expressed through the clone of the DNA sequence encoding the SEMA4D monoclonal antibody into plasmids and subsequent transfection into cell lines. Its isotype matches with the human IgG4. This SEMA4D antibody can be used in ELISA and FC applications and recognizes the SEMA4D protein from human and mouse samples. In the ELISA, mouse SEMA4D and human SEMA4D can bind to this recombinant SEMA4D antibody with the EC50 of 98.14-174.8 ng/mL and 1.082-4.805 ng/mL, respectively. It has been purified through affinity chromatography.

    SEMA4D antibody has been received increasing attention due to growing research of SEMA4D-associated diseases. Jonathan W. Goldman et al. demonstrated that the SEMA4D antibody reversed the immune balance in the tumor microenvironment (TME) and overcame immune rejection and myeloid suppression. A combination of anti-SEMA4D antibody pepinemab with the immune checkpoint inhibitor avelumab can enhance T cell infiltration and activation and lead to durable tumor regression in pre-clinical animal models with NSCLC. Yilin Mao et al. revealed that anti-SEMA4D antibody immunotherapy blocks SENA4D-Plexin B1 signaling and mitigates Rett syndrome-specific symptoms and improves cognitive and motor function in mice model with Rett syndrome.

  • Uniprot No.：
  • 基因名：
  • 別名：
    Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100), SEMA4D, C9orf164 CD100 SEMAJ
  • 反應(yīng)種屬：
    Human
  • 免疫原：
    Recombinant Human SEMA4D protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標(biāo)記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 抗體亞型：
    hIgG4(S228P)
  • 純化方式：
    Affinity-chromatography
  • 克隆號：
    21E8
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應(yīng)用范圍：
    ELISA, FC
  • 推薦稀釋比：
    Application Recommended Dilution
    FC 1:50-1:200
  • Protocols：
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

產(chǎn)品評價

靶點詳情

  • 功能：
    Cell surface receptor for PLXNB1 and PLXNB2 that plays an important role in cell-cell signaling. Regulates GABAergic synapse development. Promotes the development of inhibitory synapses in a PLXNB1-dependent manner. Modulates the complexity and arborization of developing neurites in hippocampal neurons by activating PLXNB1 and interaction with PLXNB1 mediates activation of RHOA. Promotes the migration of cerebellar granule cells. Plays a role in the immune system; induces B-cells to aggregate and improves their viability (in vitro). Induces endothelial cell migration through the activation of PTK2B/PYK2, SRC, and the phosphatidylinositol 3-kinase-AKT pathway.
  • 基因功能參考文獻(xiàn)：
    1. Combined detection of tumor-associated macrophages markers, CD68 and Sema4D, in gastric carcinoma tissue shows potential to predict the trend of gastric carcinoma progression. PMID: 29434448
    2. SEMA4D coordinates with VEGF during angiogenesis via plexin-B1 in epithelial ovarian cancer. PMID: 29308068
    3. knockdown of Sema4D in Head and neck squamous cell carcinomas (HNSCCs)cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion. PMID: 28656278
    4. The results obtained make significant adjustments in understanding of Seam4D effects in lymphoid cells. PMID: 28508207
    5. describe the transfection, purification, and visualization of Fc-tagged SEMA4D (semaphorin 4D) recombinant protein PMID: 27787840
    6. describe the application of in vitro migration and tubulogenesis assays and the directed in vivo angiogenesis assay (DIVAA) in the measurement of the angiogenic potential of cell-derived and soluble SEMA4D PMID: 27787869
    7. The positive expression of both Sema4D and PlexinB1 was found to be an independent risk factor for a worse survival in colorectal cancer. PMID: 27456345
    8. Serum levels of soluble SEMA4D were elevated in patients with ANCA-associated vasculitis. Cell-surface expression of SEMA4D was downregulated, a consequence of proteolytic cleavage of membrane SEMA4D. Soluble SEMA4D exerted pro-inflammatory effects on endothelial cells. Membranous SEMA4D on neutrophils bound to plexin B2 on endothelial cells, and this interaction decreased NET formation. PMID: 28416516
    9. We identified a novel genome-wide significant African-specific locus for BMI (SEMA4D, rs80068415). A novel variant in SEMA4D was significantly associated with body mass index. Carriers of the C allele were 4.6 BMI units heavier than carriers of the T allele. PMID: 28296344
    10. A critical pathogenic engagement of Semaphorin 4D produced by gamma delta T cells in the development of medication-related osteonecrosis of the jaw PMID: 27720716
    11. Our results identified FGL2, GAL, SEMA4D, SEMA7A, and IDO1 as new candidate genes that could be involved in MSCs-mediated immunomodulation. FGL2, GAL, SEMA4D, SEMA7A, and IDO1 genes appeared to be differentially transcribed in the different MSC populations. Moreover, these genes were not similarly modulated following MSCs-exposure to inflammatory signals PMID: 28336906
    12. Interferon-alpha-induced CD100 expression on naive CD8(+) T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction. PMID: 28222623
    13. In this review, we summarized the current findings on neuroimmune Sema4A and Sema4D molecules in chronic inflammation underlying many diseases and discussed their positive or negative impacts on the implicated molecular and cellular processes PMID: 27554682
    14. we have identified a novel reverse signaling pathway acting through Tiam1 and Rac that promotes aggressive behavior in OSCC expressing S4D and PB1. PMID: 28038319
    15. sema 4D was the direct target of miR-214 and was negatively regulated by miR-214 in ovarian cancer cells PMID: 26718213
    16. Tax and semaphorin 4D released from lymphocytes infected with human lymphotropic virus type 1 and inhibit neurite growth in a neuron cell line. PMID: 26389656
    17. This assay specifically and reproducibly measured cSEMA4D saturation and expression levels. Evaluation of the SEMA4D-specific PD markers were critical in determining the clinical saturation threshold of cSEMA4D by VX15/2503 PMID: 26566052
    18. Serum sSema4D levels are increased in patients with atrial fibrillation and are independently associated with atrial remodeling PMID: 26417899
    19. Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer. PMID: 26910109
    20. this study describes a novel immunosuppressive role for Sema4D in head and neck squamous cell carcinoma through induction of myeloid derived suppressor cells PMID: 26740106
    21. Plexin-B1 induces cutaneous squamous cell carcinoma cell proliferation, migration, and invasion by interacting with Sema4D. Plexin-B1 might serve as a useful biomarker and/or as a novel therapeutic target for cSCC. PMID: 26051877
    22. Results show that decreased expression of Sema4D, plexin-B1 and -B2 was associated with local recurrence and poor prognosis of breast neoplasm. PMID: 26035216
    23. Blocking of CD100, plexin B1 and/or B2 in adhesion experiments have shown that both CD100 and plexins act as adhesion molecules involved in monocyte-endothelial cell binding. PMID: 26275342
    24. Suggest that HIF-1alpha and Sema4D expression correlates with histological tumor type, TNM stage, and lymphatic metastasis in colorectal carcinoma. PMID: 25717256
    25. A positive feedback loop involving sSema4D/IL-6 and TNFalpha/ADAMTS-4 may contribute to the pathogenesis of rheumatoid arthritis. PMID: 25707877
    26. Sema4D contributes to enhanced invasion and tumor progression through increased motility of cervical cancer and VEGF-C/-D-mediated lymphangiogenesis. PMID: 24603190
    27. SEMA4D might possibly serve as a reliable tool for early and accurate prediction of EOC poor prognosis. PMID: 24289594
    28. results suggest that the contribution of Sema4D in platelets applies to ITAM-containing receptors as a class PMID: 24131822
    29. Sema4D could play an important role in promoting tumor proliferation, migration and metastasis in the NSCLC, by influencing the Akt protein phosphorylation. Inhibition of Sema4D may be a useful approach for the treatment of NSCLC. PMID: 25135716
    30. Data suggest that CD100 seems to be involved in hepatitis C virus (HCV) clearance by natural killer (NK) cells. PMID: 25108441
    31. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4. PMID: 24114199
    32. Elevated plasma soluble Sema4D/CD100 levels are associated with disease severity in patients of hemorrhagic fever with renal syndrome. PMID: 24040126
    33. CD100 may have a role in atherosclerotic plaque development, and may possibly be employed in targeted treatments of these atheromas. PMID: 24098722
    34. There was an increased level of plasma soluble Sema4 in the Sema4D(high) population of T-cells suggesting a potential role of these T-cells in heart failure. PMID: 23741311
    35. The membrane-proximal cytoplasmic domain of Sema4D contains a binding site for calmodulin within the polybasic region Arg762-Lys779, that regulates Sema4D exodomain shedding in platelets. PMID: 23564909
    36. copy number loss of the Sema4D gene region may play a role in the etiology of acetabular dysplasia PMID: 23335257
    37. Lycorine hydrochloride suppressed the expression of several key angiogenic genes, including VE-cadherin and Sema4D, and reduced Akt phosphorylation in Hey1B cells. PMID: 23376478
    38. CD72 mRNA expression level correlates with Sema4D expression in peripheral blood mononuclear cells in immune thrombocytopenia. PMID: 22111667
    39. CD100 protein levels were highly dysregulated around 10 weeks of gestation in first and second miscarriage placentas. The CD100 soluble form was produced and immediately shed from placental tissue in all samples. PMID: 22606231
    40. The expression of semaphorin 4D (SEMA4D), which is under the control of the HIF-family of transcription factors, cooperates with VEGF to promote tumor growth and vascularity in oral squamous cell carcinoma (OSCC). PMID: 22652457
    41. Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth. PMID: 22189792
    42. Sema4D potentiates the invasiveness of pancreatic cancer cells. The binding of Sema4D to plexinB1 induced small GTPase Ras homolog gene family, member A activation and resulted in the phosphorylation of MAPK and Akt. PMID: 21812859
    43. From the data obtained in this study, SEMA4D may have a role in more aggressive and potentially metastatic breast tumours. PMID: 21925246
    44. Rho-mediated activation of PI(4)P5K and lipid second messengers is necessary for promotion of angiogenesis by Semaphorin 4D. PMID: 21538148
    45. dysregulations in CD100 expression and release could play a role in SSc development and/or maintenance. PMID: 21244334
    46. crystal structures of cognate complexes of the semaphorin-binding regions of plexins B1 and A2 with semaphorin ectodomains (human PLXNB1(1-2)-SEMA4D(ecto) and murine PlxnA2(1-4)-Sema6A(ecto)), plus unliganded structures of PlxnA2(1-4) and Sema6A(ecto) PMID: 20877282
    47. CD100-CD72 interaction can be the mechanism by which NK cell communicate with B cells. PMID: 17786190
    48. Leukemic & normal CD5+ B cells express CD100; upon interaction between CD100 & Plexin-B1, both increase their proliferative activity & life span. CD100/Plexin-B1 crosstalk is not malignancy related but reproduces a mechanism used by normal CD5+ B cells. PMID: 12406905
    49. Soluble CD100 induces a progressive decrease in process extension of oligodendrocytes, followed by their death and the death of multipotent neural precursors. PMID: 14707103
    50. up-modulation of the survival receptor CD100 is restricted to proliferating B-cell leukemia cells PMID: 15613544

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Cell membrane; Single-pass type I membrane protein.
  • 蛋白家族：
    Semaphorin family
  • 組織特異性：
    Strongly expressed in skeletal muscle, peripheral blood lymphocytes, spleen, and thymus and also expressed at lower levels in testes, brain, kidney, small intestine, prostate, heart, placenta, lung and pancreas, but not in colon and liver.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 10732

    OMIM: 601866

    KEGG: hsa:10507

    STRING: 9606.ENSP00000348822

    UniGene: Hs.494406